HOME >> BIOLOGY >> NEWS
OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO

San Francisco, Calif. June 7, 2004 The economics and traditional structure of drug development are shifting in ways that could lead to viable markets for new, affordable drugs in the developing world if biopharmaceutical companies considered innovative collaborations with nonprofits, according to Victoria Hale, Ph.D., founder and CEO of the Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S.

Dr. Hale will speak at the BIO 2004 Annual International Convention in San Francisco as part of the Global Health track in a panel session titled "Mutually Inclusive: New and Affordable Drugs for Developed, Developing Worlds." The session will take place today, June 7, at 2:15 pm in the Moscone Convention Center, Room #2007 West.

Dr. Hale will speak about her company's proven record of collaboration that enables drug companies to partner without compromising their profitability goals. "The benefits of such collaborations are vast," stated Dr. Hale. "By working with us and other like-minded nonprofits, industry is an active partner in bringing new, affordable drugs to cure infectious diseases in the developing world, and helps to nurture new markets."

New advances in biotechnology manufacturing, splitting of intellectual property between partners to cover various geographies and indications, donations of promising but unused intellectual property, and sharing investments and risks in drug development are some of the strategies OneWorld Health uses to create collaborations with industry.

The most vital resource needed to achieve successful collaborations is people -- professionals with biopharmaceutical expertise. Dr. Hale said OneWorld Health will seek out companies that offer executive loan or sabbatical programs that would allow their employees to lend their talents to the nonprofit pharmaceutical company in specific programs.

The panel consists of:
Chair: Tom Brewer, Senior Project Offic
'"/>

Contact: Joanne Hasegawa
jhasegawa@oneworldhealth.org
415-421-4700
Institute for OneWorld Health
7-Jun-2004


Page: 1 2

Related biology news :

1. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
2. Institute for OneWorld Health nominated for the 2004 World Technology Awards
3. Institute for OneWorld Health receives Gates Foundation grant
4. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
5. OneWorld Health completes enrollment, treatment in Phase III India trial
6. Institute for OneWorld Health CEO advocates focus first on developing world markets
7. OneWorld Health plans to form network of volunteer pharmaceutical scientists for global health
8. UC Santa Barbara donates discovery to OneWorld Health that may speed disease treatment
9. Victoria Hale of Institute for OneWorld Health Named Fellow by International Womens Forum
10. Health of worlds sea lions the focus of Wakefield Symposium
11. Healthy fats and oils essential to satisfy calorie-conscious consumers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... ... and monoclonal antibody development services, today announced that the company has received ... to the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 ...
(Date:6/19/2020)... ... 16, 2020 , ... The director of stem cell biotechnology company Asymmetrex ... medicine and pharmaceutical industries have easier access to stem cell counting, they will soon ... this year, Independence Day weekend in the U.S., Asymmetrex is offering free tissue stem ...
(Date:6/11/2020)... ... June 09, 2020 , ... Superior Controls, Inc. , an ... IT solutions for the life sciences industry, is pleased to announce the recent hiring ... of the company’s Seabrook, New Hampshire office. In his new role, Boudreau will ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis Therapeutics, a biopharmaceutical company ... filed an Investigational New Drug application (IND) with the U.S. Food & Drug ... candidate NBTX-001 in patients with panic disorder (PD). , "Adding a PD trial ...
(Date:6/11/2020)... ... June 09, 2020 , ... Reducing carbon emissions has been and ... Paris Agreement to stock market dips, ways to reduce CO2 is something we can’t ... portfolio. Most of the biofuels being produced today are created from recycled cooking oil ...
(Date:5/28/2020)... ... May 28, 2020 , ... Genedata, the leading ... Genedata Screener ® 17.0, the latest version of its enterprise software for ... assay technologies. Genedata will host a webinar on June 10, 2020, detailing and ...
(Date:5/21/2020)... ... , ... Eaton Square is pleased to announce its growth on the East ... medical technology-focused strategy and M&A advisory firm. , This is an important step for ... Asia Pacific healthcare innovators with capital and investors. , Popper and Company, founded in ...
Breaking Biology Technology:
Cached News: